Parker Geoffrey M.
Insider CIK 1491874 · SNSS Director · GHDX Director · CCXI Director · ANAC Senior Vice President and CFO · PRGO Director · TCDA Chief Fin. Officer and Sr. VP · ALLO CHIEF FINANCIAL OFFICER · BTTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALLO Allogene Therapeutics, Inc | S Sale | 2026-10-21 | 2026-10-23 | 36,342 | $1.34 | $48.7K | 1,045,877 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2026-09-11 | 2026-09-15 | 1,263 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2026-09-11 | 2026-09-15 | 1,263 | $13.66 | $17.3K | 34,480 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2026-09-11 | 2026-09-15 | 607 | $13.66 | $8.3K | 33,873 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2026-09-11 | 2026-09-15 | 1,263 | — | — | 0 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2026-09-11 | 2026-09-15 | 607 | $13.66 | $8.3K | 33,873 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2026-09-11 | 2026-09-15 | 1,263 | $13.66 | $17.3K | 34,480 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2026-06-12 | 2026-06-16 | 844 | — | $0 | 844 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2026-06-12 | 2026-06-16 | 976 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2026-06-12 | 2026-06-16 | 469 | $10.99 | $5.2K | 33,217 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2026-06-12 | 2026-06-16 | 976 | $10.99 | $10.7K | 33,686 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2026-05-14 | 2026-05-15 | 7,305 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2026-05-14 | 2026-05-15 | 3,507 | $10.84 | $38.0K | 32,710 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2026-05-14 | 2026-05-15 | 7,305 | $10.84 | $79.2K | 36,217 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2026-05-13 | 2026-05-15 | 16,681 | — | $0 | 16,681 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2026-03-13 | 2026-03-17 | 3,024 | — | $0 | 3,024 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2026-02-02 | 2026-02-04 | 152,480 | — | $0 | 152,480 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2026-02-02 | 2026-02-04 | 539,072 | — | $0 | 539,072 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2026-02-02 | 2026-02-04 | 24,001 | $1.76 | $42.2K | 1,252,795 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2025-12-12 | 2025-12-16 | 2,140 | — | $0 | 2,140 | SEC↗ |
| PRGO PERRIGO Co plc | P Buy | 2025-11-12 | 2025-11-14 | 7,500 | $14.18 | $106.3K | 17,375 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2025-10-21 | 2025-10-23 | 36,744 | $1.26 | $46.3K | 1,276,796 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2025-09-12 | 2025-09-16 | 1,263 | — | $0 | 1,263 | SEC↗ |
| PRGO PERRIGO Co plc | P Buy | 2025-08-18 | 2025-08-19 | 4,375 | $22.97 | $100.5K | 33,287 | SEC↗ |
| PRGO PERRIGO Co plc | P Buy | 2025-08-18 | 2025-08-20 | 4,375 | $22.97 | $100.5K | 9,875 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2025-06-13 | 2025-06-17 | 976 | — | $0 | 976 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2025-05-14 | 2025-05-16 | 7,305 | — | $0 | 7,305 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2025-05-14 | 2025-05-16 | 9,904 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2025-05-14 | 2025-05-16 | 9,904 | $26.01 | $257.6K | 33,666 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2025-05-14 | 2025-05-16 | 4,754 | $26.01 | $123.7K | 28,912 | SEC↗ |
| PRGO PERRIGO Co plc | P Buy | 2025-05-12 | 2025-05-14 | 3,500 | $27.10 | $94.8K | 23,762 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2025-02-03 | 2025-02-05 | 4,361 | $1.73 | $7.5K | 1,301,540 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2025-01-24 | 2025-01-28 | 614,844 | — | $0 | 614,844 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2025-01-24 | 2025-01-28 | 173,913 | — | $0 | 1,305,901 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | F Tax w/h | 2024-10-21 | 2024-10-23 | 36,404 | $2.84 | $103.4K | 1,131,988 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2024-05-16 | 2024-05-20 | 344,828 | $2.90 | $1.00M | 1,164,418 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2024-05-15 | 2024-05-16 | 8,764 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2024-05-15 | 2024-05-16 | 4,207 | $30.22 | $127.1K | 20,262 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2024-05-15 | 2024-05-16 | 8,764 | $30.22 | $264.8K | 24,469 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2024-05-14 | 2024-05-16 | 9,904 | — | $0 | 9,904 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | P Buy | 2024-01-30 | 2024-03-06 | 190 | $3.60 | $684 | 819,590 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2024-01-25 | 2024-01-31 | 103,939 | — | $0 | 103,939 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2024-01-25 | 2024-01-31 | 29,400 | — | $0 | 819,400 | SEC↗ |
| BTTX Better Therapeutics, Inc. | A Award | 2023-12-18 | 2023-12-20 | 3,750 | — | $0 | 1,031,805 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2023-10-16 | 2023-10-17 | 950,000 | — | $0 | 950,000 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2023-10-16 | 2023-10-17 | 400,000 | — | $0 | 400,000 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2023-10-16 | 2023-10-17 | 390,000 | — | $0 | 790,000 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2023-07-27 | 2023-07-31 | 685,025 | $0.73 | $500.1K | 1,028,055 | SEC↗ |
| PRGO PERRIGO Co plc | P Buy | 2023-06-13 | 2023-06-14 | 10,000 | $33.06 | $330.6K | 25,879 | SEC↗ |
| BTTX Better Therapeutics, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2023-05-17 | 2023-05-19 | 7,778 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2023-05-17 | 2023-05-19 | 3,734 | $32.86 | $122.7K | 15,705 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2023-05-17 | 2023-05-19 | 7,778 | $32.86 | $255.6K | 19,439 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2023-05-15 | 2023-05-17 | 8,764 | — | $0 | 8,764 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2023-04-10 | 2023-04-12 | 303,030 | $0.83 | $251.5K | 343,030 | SEC↗ |
| PRGO PERRIGO Co plc | P Buy | 2023-03-06 | 2023-03-07 | 5,000 | $38.05 | $190.3K | 15,879 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer deriv | 2022-10-20 | 2022-10-24 | 4,504 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer deriv | 2022-10-20 | 2022-10-24 | 12,287 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer deriv | 2022-10-20 | 2022-10-24 | 13,352 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer deriv | 2022-10-20 | 2022-10-24 | 12,500 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer deriv | 2022-10-20 | 2022-10-24 | 15,723 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer deriv | 2022-10-20 | 2022-10-24 | 8,342 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer | 2022-10-20 | 2022-10-24 | 5,000 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer | 2022-10-20 | 2022-10-24 | 21,076 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer | 2022-10-20 | 2022-10-24 | 107,997 | — | $0 | 0 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2022-06-13 | 2022-06-14 | 25,000 | $1.45 | $36.3K | 40,000 | SEC↗ |
| BTTX Better Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2022-05-26 | 2022-05-31 | 8,342 | — | $0 | 8,342 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2022-05-26 | 2022-05-31 | 15,723 | — | $0 | 15,723 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2022-05-20 | 2022-05-24 | 7,726 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2022-05-20 | 2022-05-24 | 7,726 | — | $0 | 21,076 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2022-05-17 | 2022-05-19 | 6,599 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2022-05-17 | 2022-05-19 | 7,778 | — | $0 | 7,778 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2022-05-17 | 2022-05-19 | 3,168 | $38.57 | $122.2K | 11,661 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2022-05-17 | 2022-05-19 | 6,599 | $38.57 | $254.5K | 14,829 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2022-05-02 | 2022-05-03 | 12,500 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2022-05-02 | 2022-05-03 | 12,500 | $14.42 | $180.3K | 124,413 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2022-03-29 | 2022-03-31 | 15,000 | $2.15 | $32.3K | 15,000 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2022-02-28 | 2022-03-02 | 256,000 | — | $0 | 256,000 | SEC↗ |
| TCDA Tricida, Inc. | F Tax w/h | 2021-12-31 | 2022-01-04 | 1,384 | $9.56 | $13.2K | 63,617 | SEC↗ |
| PRGO PERRIGO Co plc | P Buy | 2021-12-16 | 2021-12-17 | 5,000 | $36.85 | $184.3K | 10,879 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2021-12-14 | 2021-12-16 | 20,000 | $4.94 | $98.8K | 53,333 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2021-11-15 | 2021-11-17 | 166,667 | — | $0 | 166,667 | SEC↗ |
| TCDA Tricida, Inc. | A Award | 2021-11-15 | 2021-11-17 | 166,667 | $6.00 | $1.00M | 261,667 | SEC↗ |
| BTTX Better Therapeutics, Inc. | A Award deriv | 2021-10-28 | 2021-11-01 | 28,300 | — | $0 | 28,300 | SEC↗ |
| BTTX Better Therapeutics, Inc. | A Award | 2021-10-28 | 2021-11-01 | 33,333 | — | $0 | 33,333 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2021-05-21 | 2021-05-24 | 4,660 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2021-05-21 | 2021-05-24 | 4,660 | — | $0 | 13,350 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2021-05-20 | 2021-05-24 | 4,504 | — | $0 | 4,504 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2021-05-20 | 2021-05-24 | 7,726 | — | $0 | 7,726 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2021-05-17 | 2021-05-19 | 6,599 | — | $0 | 6,599 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2021-05-07 | 2021-05-11 | 5,804 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2021-05-07 | 2021-05-11 | 5,804 | $42.96 | $249.3K | 14,245 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2021-05-07 | 2021-05-11 | 2,786 | $42.96 | $119.7K | 11,459 | SEC↗ |
| PRGO PERRIGO Co plc | P Buy | 2021-03-17 | 2021-03-18 | 2,500 | $41.29 | $103.2K | 2,650 | SEC↗ |
| CCXI ChemoCentryx, Inc. | G Gift | 2021-03-10 | 2021-05-24 | 4,000 | — | $0 | 8,690 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2021-03-05 | 2021-03-08 | 16,670 | $56.78 | $946.5K | 26,020 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2021-03-05 | 2021-03-08 | 13,330 | $55.89 | $745.0K | 12,690 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2021-03-04 | 2021-03-08 | 1,910 | $60.20 | $115.0K | 42,690 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2021-01-17 | 2021-01-20 | 216,000 | — | $0 | 216,000 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2020-12-10 | 2020-12-10 | 15,000 | $6.78 | $101.7K | 40,000 | SEC↗ |
| TCDA Tricida, Inc. | A Award | 2020-09-10 | 2020-09-14 | 4,000 | — | $0 | 60,837 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2020-05-23 | 2020-05-26 | 7,724 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2020-05-23 | 2020-05-26 | 7,724 | — | $0 | 111,913 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2020-05-21 | 2020-05-26 | 2,888 | — | $0 | 2,888 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2020-05-21 | 2020-05-26 | 4,660 | — | $0 | 4,660 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2020-05-15 | 2020-05-19 | 6,054 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2020-05-15 | 2020-05-19 | 6,054 | $52.76 | $319.4K | 11,347 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2020-05-15 | 2020-05-19 | 2,906 | $52.76 | $153.3K | 8,441 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2020-05-12 | 2020-05-12 | 1,303 | $30.09 | $39.2K | 93,561 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2020-05-12 | 2020-05-12 | 1,439 | $31.66 | $45.6K | 95,000 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2020-05-11 | 2020-05-12 | 12,404 | $29.48 | $365.7K | 72,404 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2020-05-11 | 2020-05-12 | 19,854 | $30.36 | $602.8K | 92,258 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2020-05-07 | 2020-05-11 | 5,804 | — | $0 | 5,804 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2020-03-23 | 2020-03-25 | 13,959 | $37.40 | $522.1K | 50,460 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2020-03-23 | 2020-03-25 | 860 | $38.21 | $32.9K | 49,600 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2020-03-23 | 2020-03-25 | 9,181 | $36.72 | $337.1K | 64,419 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2020-03-23 | 2020-03-25 | 3,199 | $34.43 | $110.1K | 76,401 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2020-03-23 | 2020-03-25 | 2,801 | $35.32 | $98.9K | 73,600 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2020-03-10 | 2020-03-11 | 5,000 | $29.46 | $147.3K | 55,000 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2020-02-24 | 2020-02-26 | 130,000 | — | $0 | 130,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2019-12-02 | 2019-12-04 | 31,990 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2019-12-02 | 2019-12-04 | 31,990 | $6.00 | $191.9K | 104,189 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2019-11-19 | 2019-11-19 | 945 | $34.72 | $32.8K | 50,000 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2019-11-18 | 2019-11-19 | 19,055 | $34.28 | $653.2K | 49,055 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer deriv | 2019-11-08 | 2019-11-14 | 10,000 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer deriv | 2019-11-08 | 2019-11-14 | 10,000 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer deriv | 2019-11-08 | 2019-11-14 | 6,583 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer deriv | 2019-11-08 | 2019-11-14 | 20,000 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2019-11-08 | 2019-11-14 | 955 | — | $0 | 0 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise deriv | 2019-09-03 | 2019-09-04 | 54,347 | — | $0 | 196,909 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise | 2019-09-03 | 2019-09-04 | 54,347 | $1.84 | $100.0K | 56,122 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2019-08-22 | 2019-08-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2019-08-13 | 2019-08-14 | 4,531 | $33.60 | $152.2K | 30,000 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2019-08-13 | 2019-08-14 | 7,416 | $32.91 | $244.1K | 25,469 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2019-08-12 | 2019-08-14 | 2,577 | $32.56 | $83.9K | 18,053 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2019-08-12 | 2019-08-14 | 15,476 | $31.64 | $489.7K | 15,476 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2019-06-14 | 2019-06-18 | 6,583 | — | $0 | 6,583 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2019-06-14 | 2019-06-18 | 955 | — | $0 | 955 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2019-05-30 | 2019-06-03 | 18,010 | — | $0 | 31,990 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2019-05-30 | 2019-06-03 | 12,815 | $12.00 | $153.8K | 72,199 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2019-05-30 | 2019-06-03 | 18,010 | $6.00 | $108.1K | 85,014 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2019-05-23 | 2019-05-23 | 12,287 | — | $0 | 12,287 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2019-05-23 | 2019-05-23 | 7,724 | — | $0 | 7,724 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2019-05-21 | 2019-05-23 | 8,421 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2019-05-21 | 2019-05-23 | 8,421 | — | $0 | 67,004 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2019-05-15 | 2019-05-17 | 3,971 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2019-05-15 | 2019-05-17 | 6,054 | — | $0 | 6,054 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2019-05-15 | 2019-05-17 | 1,907 | $49.55 | $94.5K | 5,293 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2019-05-15 | 2019-05-17 | 3,971 | $49.55 | $196.8K | 7,200 | SEC↗ |
| TCDA Tricida, Inc. | A Award | 2019-04-04 | 2019-04-08 | 20,000 | $36.00 | $720.0K | 25,000 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2019-02-20 | 2019-02-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2018-11-13 | 2018-11-13 | 5,000 | $29.72 | $148.6K | 65,000 | SEC↗ |
| PRGO PERRIGO Co plc | P Buy | 2018-11-12 | 2018-11-13 | 3,000 | $65.35 | $196.0K | 5,500 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2018-07-02 | 2018-07-02 | 60,000 | $19.00 | $1.14M | 60,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2018-06-07 | 2018-06-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2018-06-06 | 2018-06-08 | 4,265 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2018-06-06 | 2018-06-08 | 2,048 | $73.22 | $150.0K | 3,229 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2018-06-06 | 2018-06-08 | 4,265 | $73.22 | $312.3K | 5,277 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2018-05-25 | 2018-05-30 | 12,912 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2018-05-25 | 2018-05-30 | 12,912 | — | $0 | 58,583 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2018-05-21 | 2018-05-23 | 8,421 | — | $0 | 8,421 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2018-05-21 | 2018-05-23 | 13,352 | — | $0 | 13,352 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2018-05-15 | 2018-05-17 | 3,971 | — | $0 | 3,971 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2017-07-20 | 2017-07-24 | 511 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2017-07-20 | 2017-07-24 | 1,437 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2017-07-20 | 2017-07-24 | 511 | $75.51 | $38.6K | 1,258 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2017-07-20 | 2017-07-24 | 246 | $75.51 | $18.6K | 1,012 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2017-07-20 | 2017-07-24 | 1,437 | $75.51 | $108.5K | 1,437 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2017-07-20 | 2017-07-24 | 690 | $75.51 | $52.1K | 747 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2017-06-16 | 2017-06-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2017-06-06 | 2017-06-08 | 1,437 | — | $0 | 1,437 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2017-06-06 | 2017-06-08 | 4,265 | — | $0 | 4,265 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2017-05-31 | 2017-06-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2017-05-26 | 2017-05-30 | 20,362 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2017-05-26 | 2017-05-30 | 20,362 | — | $0 | 45,671 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2017-05-25 | 2017-05-30 | 12,912 | — | $0 | 12,912 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy | 2016-12-09 | 2016-12-12 | 594 | $3.90 | $2.3K | 65,745 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy | 2016-12-09 | 2016-12-16 | 594 | $3.90 | $2.3K | 14,074 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy | 2016-12-08 | 2016-12-12 | 3,146 | $3.87 | $12.2K | 65,151 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy | 2016-12-08 | 2016-12-16 | 3,146 | $3.87 | $12.2K | 13,480 | SEC↗ |
| PRGO PERRIGO Co plc | P Buy | 2016-11-21 | 2016-11-21 | 2,500 | $88.75 | $221.9K | 2,500 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2016-11-17 | 2017-05-03 | 511 | — | $0 | 511 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2016-11-17 | 2016-11-18 | 511 | — | $0 | 511 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2016-06-21 | 2016-06-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2016-05-26 | 2016-05-27 | 20,362 | — | $0 | 20,362 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy | 2016-05-26 | 2016-05-27 | 9,500 | $0.47 | $4.5K | 62,005 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy | 2016-05-25 | 2016-05-26 | 22,505 | $0.49 | $11.0K | 52,505 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy | 2016-05-24 | 2016-05-26 | 30,000 | $0.46 | $13.8K | 30,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2016-05-21 | 2016-05-24 | 11,795 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2016-05-21 | 2016-05-24 | 11,795 | — | $0 | 25,309 | SEC↗ |
| CCXI ChemoCentryx, Inc. | P Buy | 2016-05-13 | 2016-05-13 | 40,000 | $4.03 | $161.2K | 99,600 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2016-03-31 | 2016-04-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | P Buy | 2016-01-11 | 2016-01-11 | 20,000 | $4.63 | $92.6K | 59,600 | SEC↗ |
| CCXI ChemoCentryx, Inc. | P Buy | 2015-12-11 | 2015-12-14 | 4,621 | $7.30 | $33.7K | 39,600 | SEC↗ |
| CCXI ChemoCentryx, Inc. | P Buy | 2015-12-10 | 2015-12-14 | 15,379 | $7.23 | $111.2K | 34,979 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2015-05-27 | 2015-05-29 | 13,513 | $7.51 | $101.5K | 13,514 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2015-05-22 | 2015-05-26 | 27,027 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2015-05-22 | 2015-05-26 | 27,027 | — | $0 | 27,027 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2015-05-21 | 2015-05-26 | 11,795 | — | $0 | 11,795 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | P Buy | 2015-03-23 | 2015-03-23 | 3,000 | $52.43 | $157.3K | 173,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2015-02-03 | 2015-02-05 | 6,930 | — | $0 | 6,930 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2015-02-03 | 2015-02-05 | 28,400 | — | $0 | 28,400 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award | 2015-02-03 | 2015-02-05 | 6,840 | — | $0 | 94,840 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | P Buy | 2014-09-08 | 2014-09-08 | 1,229 | $22.05 | $27.1K | 170,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | P Buy | 2014-09-05 | 2014-09-08 | 5,361 | $21.77 | $116.7K | 168,771 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2014-05-29 | 2014-05-30 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2014-05-22 | 2014-05-23 | 27,027 | — | $0 | 27,027 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | P Buy | 2014-03-24 | 2014-03-24 | 5,000 | $20.11 | $100.5K | 163,410 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | P Buy | 2014-03-18 | 2014-03-19 | 2,410 | $22.60 | $54.5K | 158,410 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2014-02-07 | 2014-02-10 | 54,000 | — | $0 | 54,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | P Buy | 2013-12-06 | 2013-12-09 | 15,000 | $5.15 | $77.3K | 15,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | P Buy | 2013-12-06 | 2013-12-09 | 5,000 | $5.15 | $25.8K | 9,600 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | P Buy | 2013-11-26 | 2013-11-27 | 10,000 | $13.40 | $134.0K | 156,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | P Buy | 2013-11-25 | 2013-11-26 | 10,000 | $12.85 | $128.5K | 146,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | X Exercise deriv | 2013-10-04 | 2013-10-04 | 80,000 | $5.00 | $400.0K | 101,579 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | X Exercise | 2013-10-04 | 2013-10-04 | 80,000 | $5.00 | $400.0K | 85,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | P Buy | 2013-08-13 | 2013-08-13 | 50,000 | $8.34 | $417.0K | 136,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | P Buy | 2013-06-19 | 2013-06-19 | 23,046 | $5.20 | $119.8K | 86,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | P Buy | 2013-06-18 | 2013-06-18 | 10,000 | $5.22 | $52.2K | 62,954 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | P Buy | 2013-06-18 | 2013-06-18 | 10,000 | $5.22 | $52.2K | 10,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2013-05-23 | 2013-05-28 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2013-04-12 | 2013-04-16 | 120,000 | — | $0 | 120,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | P Buy | 2012-08-22 | 2012-08-24 | 5,000 | $6.19 | $31.0K | 55,954 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2012-06-22 | 2012-06-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | P Buy | 2012-06-05 | 2012-06-05 | 4,314 | $4.93 | $21.3K | 49,954 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | P Buy | 2012-06-04 | 2012-06-05 | 3,640 | $4.68 | $17.0K | 45,640 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | P Buy | 2012-03-20 | 2012-03-20 | 9,400 | $6.08 | $57.2K | 42,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | P Buy | 2012-03-19 | 2012-03-20 | 600 | $6.03 | $3.6K | 32,600 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | A Award deriv | 2012-03-13 | 2012-03-14 | 55,000 | — | $0 | 55,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | P Buy | 2012-02-10 | 2012-02-13 | 4,600 | $10.97 | $50.5K | 4,600 | SEC↗ |